Dr. Reddy's Lab moves up on getting EIR for formulations Srikakulum plant in Andhra Pradesh

14 May 2020 Evaluate
Dr. Reddy’s Laboratories is currently trading at Rs. 3799.95, up by 17.55 points or 0.46% from its previous closing of Rs. 3782.40 on the BSE.

The scrip opened at Rs. 3782.50 and has touched a high and low of Rs. 3816.00 and Rs. 3756.20 respectively. So far 5867 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 4099.90 on 08-May-2020 and a 52 week low of Rs. 2352.00 on 14-Aug-2019.

Last one week high and low of the scrip stood at Rs. 4099.90 and Rs. 3737.65 respectively. The current market cap of the company is Rs. 63211.86 crore.

The promoters holding in the company stood at 26.76%, while Institutions and Non-Institutions held 45.14% and 13.80% respectively.

Dr. Reddy's Laboratories has received the Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for formulations Srikakulum plant (SEZ) Unit I, Andhra Pradesh, indicating closure of the audit and the inspection classification of this facility is determined as No Action Indicated (NAI).

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Lab Share Price

1272.00 -7.00 (-0.55%)
17-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1795.10
Dr. Reddys Lab 1272.00
Cipla 1496.95
Zydus Lifesciences 918.35
Lupin 2113.15
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×